RPH Central Pharma – 1st Central Radiopharmacy of Brazil

 

With great pride we´d like to inform that after years of great dedication to the 1st Centralized Radiopharmacy of Brazil, RPH Central Pharma, received from Brazilian Health Regulatory Agency (ANVISA), the Operation  License  (AFE), according to the resolution Nº 3,046. The resolution was published in the Brazilian Federal Register (DOU) of November 12, 2018.

We reinforce that this is a great milestone in the history of the RPH Group and we are glad to be able to bring an innovative model of radiopharmacy to Brazilian Nuclear Medicine.